Aqr Capital Management LLC Bridge Bio Pharma, Inc. Transaction History
Aqr Capital Management LLC
- $75.6 Billion
- Q4 2024
A detailed history of Aqr Capital Management LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 223,573 shares of BBIO stock, worth $7.66 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
223,573
Previous 195,963
14.09%
Holding current value
$7.66 Million
Previous $4.99 Million
22.95%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding BBIO
# of Institutions
321Shares Held
176MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$865 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$860 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$516 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$426 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$212 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.08B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...